NDAORALCAPSULE, DELAYED RELEASE
Approved
Mar 2013
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
20
Clinical Trials (5)
Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus
Started Jan 2026
A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS)
Started Sep 2025
A Study to Evaluate Long-Term Safety of Vumerity and Tecfidera in Participants With Multiple Sclerosis (MS)
Started Jun 2024
10,500 enrolled
Multiple Sclerosis
A Study of Dimethyl Fumarate (DMF) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in China
Started Jun 2023
60 enrolled
Multiple Sclerosis
Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera
Started Mar 2021
1,507 enrolled
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Loss of Exclusivity
LOE Date
Nov 16, 2035
118 months away
Patent Expiry
Nov 16, 2035